Our Center for Cancer and Blood Disorders specialists provide innovative pediatric hematology, oncology, bone marrow transplant and cellular therapeutic care. We’re committed to improving care for children with cancer and blood disorders at our care locations and around the world. Watch the provider education videos below to learn from our pediatric oncology and hematology experts.
Non-malignant bone marrow transplant for hematologic diseases
Our Blood and Marrow Transplant and Cellular Therapeutics team cares for children and young adults with a variety of malignant and non-malignant conditions. Over the last three years, our team has completed an average of 20 non-malignant bone marrow transplants per year, approximately 30% of all transplants.
In this video, assistant professor Jessica Knight-Perry, MD, provides an overview of our non-malignant transplant program and the pediatric hematologic conditions we treat, including sickle cell disease, thalassemia and bone marrow failure. Learn how we’re improving hematopoietic cell transplantation for pediatric patients with these conditions.
Iron Deficiency Anemia (IDA) in Children and Young Adults
Treating iron deficiency anemia (IDA) in children through diet alone may fail to address the root of the problem. Taizo Nakano, MD, PHD, is a doctor with our Center for Cancer and Blood Diseases (CCBD) as well as the Medical Director of our Vascular Anomalies Center. In this video, Dr. Nakano explains the range of possible causes for IDA, looking beyond the baseline factor of adequate dietary intake. To get to the source of IDA, Dr. Nakano explains that doctors must look at other factors such as appropriate absorption, storage and utilization of iron. Watch to learn about the nuances of diagnosing and treating IDA, as well as the important differences between IDA and Thalassemia.
Diagnosis and Management of Sickle Cell Disease
The Hematology Program at Children’s Colorado is internationally recognized for expertise in hemophilia, bleeding and clotting disorders, hematological diseases and immuno-hematological diseases. In this video, assistant professor Christopher McKinney, MD, talks about the diagnosis and management of patients with sickle cell disease and briefly reviews new and emerging treatment options.
Use of Droplet Digital PCR to Measure Residual Disease in Acute Myeloid Leukemia
Roughly one-third of children and up to two-thirds of adults with acute myeloid leukemia (AML) experience relapse – even after the most aggressive treatments. The use of droplet digital polymerase chain reaction (PCR) to measure residual disease in AML may help doctors detect the potential for relapse with better accuracy.
Amanda C. Winters, MD, PhD, is a doctor with the Center for Cancer and Blood Disorders at Children’s Hospital Colorado. In this video, Dr. Winters discusses ongoing research into droplet digital PCR, and how it holds the potential for improving AML outcomes in both children and adults.